MOLECULAR GENETIC TESTING OF OSTEOPOROSIS SUSCEPTIBILITY IN POSTMENOPAUSAL WOMEN IN MOSCOW

MOLECULAR GENETIC TESTING OF OSTEOPOROSIS SUSCEPTIBILITY IN POSTMENOPAUSAL WOMEN IN MOSCOW

Polymorphisms of 21 genes involved in the processes of bone remodeling were studied on samples of 150 to 265 postmenopausal healthy women in a control group and those of 175 to 269 patients with osteoporosis (OP). In a Moscow sample of postmenopausal women, the genotypes of OP susceptibility were fo...

Full description

Bibliographic Details
Main Authors:	V A Myakotkin, M Yu Krylov, I A Guseva, E V Chetina, N V Toroptsova, O A Nikitinskaya, E Yu Samarkina, L I Benevolenskaya
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2011-04-01
Series:	Научно-практическая ревматология
Subjects:	genetic polymorphism gene interaction osteoporosis postmenopause
Online Access:	https://rsp.mediar-press.net/rsp/article/view/735

Similar Items

Estrogenic receptors a and p gene polymorphisms in postmenopausal osteoporosis
by: K A Maslova, et al.
Published: (2008-06-01)

Association of transforming growth factor (TGF) p1 T(861-20)C polymorphism with bone mineral density and TGFip gene expression in postmenopausal osteoporosis
by: Elena Vasilyevna Chetina, et al.
Published: (2012-04-01)

STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2017-07-01)

Mineral bone density association with estrogen alpha receptor gene (ESRa) polymorphisms at postmenopausal osteoporosis
by: M Y Krylov, et al.
Published: (2005-02-01)

ASSOCIATION OF INTERLEUKIN-1β GENE POLYMORPHISM WITH POSTMENOPAUSAL OSTEOPOROSIS IN WOMEN IN THE RUSSIAN POPULATION
by: M. Yu. Krylov, et al.
Published: (2015-10-01)

Transforming growth factor β1 gene polymorphism in postmenopausal osteoporosis
by: M Y Krylov, et al.
Published: (2009-02-01)

Search for genetic markers determining the efficiency of therapy with bisphosphonates in Russian women with postmenopausal osteoporosis: A pilot study
by: M. Yu. Krylov, et al.
Published: (2016-10-01)

FARNESYL DIPHOSPHATE SYNTHASE (FDRS) AND GERANYLGERANYL DIPHOSPHATE SYNTHASE (GGSP1) GENE POLYMORPHISMS AND EFFICIENCY OF THERAPY WITH BISPHOSPHONATES IN RUSSIAN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2016-03-01)

LEPTIN A19G POLYMORPHISM AND LEPTIN RECEPTOR Gln223Arg AND Lys109Arg POLYMORPHISMSIN POSTMENOPAUSAL OSTEOPOROSIS
by: Mikhail Yur'evich Krylov, et al.
Published: (2010-10-01)

Allele polymorphism of alkaline, acid soluble phosphatase genes and vitamin D-binding protein in postmenopausal osteoporosis
by: M Yu Krylov, et al.
Published: (2004-05-01)

Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01)

THREE YEARS' EXPERIENCE WITH THE BIOLOGICAL AGENT DENOSUMAB USED TO TREAT WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: EFFICACY, SAFETY AND TREATMENT ADHERENCE
by: N. V. Toroptsova, et al.
Published: (2017-07-01)

Primary osteoporosis prophylaxis with different calcium preparations
by: N. V. Toroptsova, et al.
Published: (2005-02-01)

Adherence to treatment with denosumab, its efficacy and safety in women with postmenopausal osteoporosis in clinical practice
by: N. V. Toroptsova, et al.
Published: (2016-01-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Analysis of alkaline phosphatase, soluble acid phosphatase, low density lipoprotein and vitamin D binding protein gene polymorphisms as possible gene-candidates participating in mineral bone density determination in women with primary osteoporosis in postmenopause
by: M Y Krylov, et al.
Published: (2004-06-01)

Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01)

Assessment of genes LRP5, BVP4, TGF^l polymorphisms significance in postmenopausal osteoporosis
by: KA Myakotkin, et al.
Published: (2008-06-01)

New view of the prevention of osteoporosis: focus on Calcium-D3 Nycomed
by: N V Toroptsova, et al.
Published: (2007-09-01)

New view of the prevention of osteoporosis: focus on Calcium-D3 Nycomed
by: N V Toroptsova, et al.
Published: (2007-09-01)

THE EXPRESSION OF GENES ASSOCIATED WITH OSTEOBLAST DIFFERENTIATION AND THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) IN THE BLOOD OF PATIENTS WITH OSTEOPOROSIS
by: E. V. Chetina, et al.
Published: (2011-06-01)

Osteoporosis and cardiovascular diseases
by: S G Anikin, et al.
Published: (2009-08-01)

OSTEOPOROSIS TREATMENT ADHERENCE: RESULTS FROM A RETROSPECTIVE COHORT STUDY
by: O. A. Nikitinskaya, et al.
Published: (2019-09-01)

Prophylaxis of primary osteoporosis in women with complex drug Calcemin Advance (results of an open year’s study)
by: O A Nikitinskaya, et al.
Published: (2008-06-01)

The use of bisphosphonates for the treatment and prevention of osteoporosis
by: O. A. Nikitinskaya, et al.
Published: (2022-08-01)

Efficacy and safety of bivalos therapy for postmenopausal osteoporosis. results of russian multicenter trial
by: L Ia Rozhinskaia, et al.
Published: (2008-05-01)

THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
by: O. A. Nikitinskaya, et al.
Published: (2018-09-01)

To the 100th anniversary of the birth of academician V.A. Nasonova. Osteoporosis: Yesterday, today, tomorrow
by: N. V. Toroptsova, et al.
Published: (2023-06-01)

Risk factors for osteoporosis in men aged 40 years or older: the results of the program «Osteoscreening-Russia»
by: O. A. Nikitinskaya, et al.
Published: (2018-09-01)

TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE
by: N. V. Toroptsova, et al.
Published: (2014-06-01)

Progress of osteoporosis: stratification of fracture risk
by: Oksana A. Nikitinskaya, et al.
Published: (2018-04-01)

Osteoporosis and its complications: treatment adherence and possibilities of its enhancement
by: O V Dobrovol'skaya, et al.
Published: (2011-09-01)

Osteoporosis and its complications: treatment adherence and possibilities of its enhancement
by: O V Dobrovol'skaya, et al.
Published: (2011-09-01)

Risk factors and bone mineral density in predicting the risk of fracture in postmenopausal women
by: O. A. Nikitinskaya, et al.
Published: (2016-09-01)

Clinical practice: the place of calcium supplements and vitamin D in the treatment of osteoporosis
by: O. V. Dobrovolskaya, et al.
Published: (2021-07-01)

THE INFLUENCE OF POSTMENOPAUSAL OSTEOPOROSIS AND SUBCLINICAL VERTEBRAL FRACTURES ON POSTMENOPAUSAL WOMEN’S QUALITY OF LIFE
by: L. A. Marchenkova, et al.
Published: (2016-02-01)

Denosumab is the first gene engineered agent for the treatment of osteoporosis
by: O A Nikitinskaya, et al.
Published: (2012-09-01)

Osteoporosis in women in menopause/postmenopause: what to do?
by: E. V. Kulchavenya, et al.
Published: (2021-01-01)

ASSESSMENT OF 10-YEAR PROBABILITY OF OSTEOPOROTIC FRACTURES WITH THE RUSSIAN MODEL OF FRAX® IN A POPULATION-BASED SAMPLE 5 REGIONS OF RUSSIA
by: O. A. Nikitinskaya, et al.
Published: (2017-12-01)

NOVYY BISFOSFONAT BONVIVADLYa LEChENIYa POSTMENOPAUZAL'NOGO OSTEOPOROZA
by: N V TOROPTsOVA, et al.
Published: (2006-08-01)